NO20084987L - Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel - Google Patents
Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddelInfo
- Publication number
- NO20084987L NO20084987L NO20084987A NO20084987A NO20084987L NO 20084987 L NO20084987 L NO 20084987L NO 20084987 A NO20084987 A NO 20084987A NO 20084987 A NO20084987 A NO 20084987A NO 20084987 L NO20084987 L NO 20084987L
- Authority
- NO
- Norway
- Prior art keywords
- nicotine
- trometamol
- pharmaceutical product
- buffering agent
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Zoology (AREA)
- Addiction (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0601090 | 2006-05-16 | ||
PCT/SE2007/000365 WO2007133141A1 (en) | 2006-05-16 | 2007-04-18 | Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20084987L true NO20084987L (no) | 2009-02-16 |
Family
ID=38694149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20084987A NO20084987L (no) | 2006-05-16 | 2008-11-27 | Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel |
Country Status (16)
Country | Link |
---|---|
US (1) | US20070269492A1 (pt) |
EP (1) | EP2023928A4 (pt) |
JP (1) | JP5254213B2 (pt) |
KR (1) | KR101414063B1 (pt) |
CN (1) | CN101472591A (pt) |
AR (1) | AR060931A1 (pt) |
AU (1) | AU2007250589B2 (pt) |
BR (1) | BRPI0712068A2 (pt) |
CA (1) | CA2652500C (pt) |
MX (1) | MX2008014726A (pt) |
NO (1) | NO20084987L (pt) |
NZ (1) | NZ572758A (pt) |
RU (1) | RU2448707C2 (pt) |
TW (1) | TW200810755A (pt) |
WO (1) | WO2007133141A1 (pt) |
ZA (1) | ZA200810618B (pt) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
US8642016B2 (en) | 2006-07-21 | 2014-02-04 | Jsrnti, Llc | Medicinal delivery system, and related methods |
JP2010523587A (ja) * | 2007-04-02 | 2010-07-15 | パーキンソンズ インスティテュート | 治療処置の副作用の低減のための方法および組成物 |
GB2468424B (en) * | 2007-04-02 | 2011-11-09 | Parkinson S Inst | Methods and compositions for reduction of side effects of therapeutic treatments |
US20080286341A1 (en) * | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered coated nicotine containing products |
AU2013219211B2 (en) * | 2008-05-01 | 2016-05-12 | Glaxosmithkline Llc | Nicotine lozenge compositions |
CL2009001025A1 (es) * | 2008-05-01 | 2010-09-24 | Smithkline Beecham Corp | Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco. |
EP2177213B1 (en) | 2008-09-17 | 2013-01-02 | Siegfried Ltd. | Nicotine-containing granulate |
JP2012505878A (ja) | 2008-10-14 | 2012-03-08 | マクニール アーベー | 複数部分口内剤形及びその使用 |
PL2198865T3 (pl) | 2008-12-19 | 2012-04-30 | Siegfried Ltd | Produkt zawierający nikotynę |
US20100247586A1 (en) * | 2009-03-27 | 2010-09-30 | Andreas Hugerth | Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties |
EP2442668B1 (en) * | 2009-06-19 | 2016-08-10 | Fertin Pharma A/S | Buffered gum base for high ph release |
WO2011101860A1 (en) * | 2010-02-18 | 2011-08-25 | Jatin Vasant Thakkar | Nicotine-containing soft gelatin pastilles |
US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
CA2841785A1 (en) | 2011-07-06 | 2013-01-10 | The Parkinson's Institute | Compositions and methods for treatment of symptoms in parkinson's disease patients |
US9629392B2 (en) | 2011-09-22 | 2017-04-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9084439B2 (en) | 2011-09-22 | 2015-07-21 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9474303B2 (en) | 2011-09-22 | 2016-10-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
US20130177646A1 (en) * | 2012-01-05 | 2013-07-11 | Mcneil Ab | Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance |
US9763928B2 (en) | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
US9044035B2 (en) | 2012-04-17 | 2015-06-02 | R.J. Reynolds Tobacco Company | Remelted ingestible products |
FR2993778B1 (fr) * | 2012-07-30 | 2016-06-17 | Pf Medicament | Pastilles a cinetiques multiples de liberation de principes actifs |
CN102926277B (zh) * | 2012-11-14 | 2015-05-20 | 湖南中烟工业有限责任公司 | 一种β-环糊精-g-乳酸共聚物的应用 |
US9375033B2 (en) | 2014-02-14 | 2016-06-28 | R.J. Reynolds Tobacco Company | Tobacco-containing gel composition |
CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
JP2018511127A (ja) | 2015-03-12 | 2018-04-19 | クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. | 渇望入力及び支援システム |
US20170172995A1 (en) * | 2015-09-08 | 2017-06-22 | Venkateswara Rao Repaka | Pharmaceutical compositions of Nicotine and process for preparation thereof |
US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
WO2018129304A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
PL3720418T3 (pl) * | 2017-12-08 | 2021-12-20 | Fertin Pharma A/S | Tabletka nikotynowa |
US11596779B2 (en) | 2018-05-29 | 2023-03-07 | Morningside Venture Investments Limited | Drug delivery methods and systems |
AU2019301234A1 (en) | 2018-07-13 | 2020-12-24 | Mcneil Ab | Chewing gum comprising nicotine |
US20230053622A1 (en) | 2020-01-15 | 2023-02-23 | Mcneil Ab | Lozenge |
AU2022369049A1 (en) * | 2021-10-21 | 2024-06-06 | Mcneil Ab | Nicotine chewing gum |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3901248A (en) * | 1970-07-22 | 1975-08-26 | Leo Ab | Chewable smoking substitute composition |
US3877468A (en) * | 1970-07-22 | 1975-04-15 | Leo Ab | Chewable tobacco substitute composition |
US3845217A (en) * | 1972-11-16 | 1974-10-29 | Helsingborg L Ab | Buffered smoking substitute compositions |
GB8301659D0 (en) * | 1983-01-21 | 1983-02-23 | Leo Ab | Smoking substitutes |
US5783207A (en) * | 1985-05-01 | 1998-07-21 | University Of Utah Research Foundation | Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine |
GB8615676D0 (en) * | 1986-06-26 | 1986-07-30 | Stoppers Co Ltd | Nicotine containing lozenge |
US5004651A (en) * | 1989-01-24 | 1991-04-02 | Abbott Laboratories | Stabilizing system for solid dosage forms |
US5824334A (en) * | 1989-09-05 | 1998-10-20 | University Of Utah Research Foundation | Tobacco substitute |
US5167242A (en) * | 1990-06-08 | 1992-12-01 | Kabi Pharmacia Aktiebolaq | Nicotine-impermeable container and method of fabricating the same |
BR9207062A (pt) * | 1992-01-06 | 1995-10-24 | Du Pont | Formulação em comprimido |
SE9303574D0 (sv) * | 1993-11-01 | 1993-11-01 | Kabi Pharmacia Ab | Composition for drug delivery and method the manufacturing thereof |
US5889028A (en) * | 1996-02-09 | 1999-03-30 | Mayo Foundation For Medical Education And Research | Colonic delivery of nicotine to treat inflammatory bowel disease |
US5810081A (en) * | 1997-02-24 | 1998-09-22 | Cobb; Delwin E. | Wear structure for bore hole separation device |
US6264981B1 (en) * | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
US20030175349A1 (en) * | 2001-01-30 | 2003-09-18 | Council Of Scientific And Industrial Research | Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient |
SE0102197D0 (sv) * | 2001-06-20 | 2001-06-20 | Pharmacia Ab | New product and use and manufacture thereof |
US20040037879A1 (en) * | 2001-11-02 | 2004-02-26 | Adusumilli Prasad S. | Oral controlled release forms useful for reducing or preventing nicotine cravings |
CA2483099A1 (en) * | 2002-05-03 | 2003-11-13 | Hexal Ag | Stable pharmaceutical formulation for a combination of a statin and an ace inhibitor |
US7157100B2 (en) * | 2002-06-04 | 2007-01-02 | J.B. Chemicals & Pharmaceuticals Ltd. | Pharmaceutical composition for controlled drug delivery system |
US20030049307A1 (en) * | 2002-08-15 | 2003-03-13 | Gyurik Robert J. | Pharmaceutical composition |
US20040052851A1 (en) * | 2002-09-16 | 2004-03-18 | Graff Allan H. | Modified release oral dosage form |
-
2006
- 2006-06-01 US US11/444,775 patent/US20070269492A1/en not_active Abandoned
-
2007
- 2007-04-18 NZ NZ572758A patent/NZ572758A/en not_active IP Right Cessation
- 2007-04-18 JP JP2009510917A patent/JP5254213B2/ja not_active Expired - Fee Related
- 2007-04-18 KR KR1020087030673A patent/KR101414063B1/ko active IP Right Grant
- 2007-04-18 AU AU2007250589A patent/AU2007250589B2/en not_active Ceased
- 2007-04-18 EP EP07748030A patent/EP2023928A4/en not_active Withdrawn
- 2007-04-18 CA CA2652500A patent/CA2652500C/en not_active Expired - Fee Related
- 2007-04-18 WO PCT/SE2007/000365 patent/WO2007133141A1/en active Application Filing
- 2007-04-18 RU RU2008149508/15A patent/RU2448707C2/ru not_active IP Right Cessation
- 2007-04-18 MX MX2008014726A patent/MX2008014726A/es active IP Right Grant
- 2007-04-18 BR BRPI0712068-0A patent/BRPI0712068A2/pt not_active Application Discontinuation
- 2007-04-18 CN CNA2007800232492A patent/CN101472591A/zh active Pending
- 2007-05-15 TW TW096117125A patent/TW200810755A/zh unknown
- 2007-05-15 AR ARP070102085A patent/AR060931A1/es not_active Application Discontinuation
-
2008
- 2008-11-27 NO NO20084987A patent/NO20084987L/no not_active Application Discontinuation
- 2008-12-15 ZA ZA2008/10618A patent/ZA200810618B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2007250589B2 (en) | 2011-04-14 |
KR20090024161A (ko) | 2009-03-06 |
AR060931A1 (es) | 2008-07-23 |
TW200810755A (en) | 2008-03-01 |
MX2008014726A (es) | 2009-02-04 |
RU2008149508A (ru) | 2010-06-27 |
CA2652500C (en) | 2014-07-29 |
RU2448707C2 (ru) | 2012-04-27 |
US20070269492A1 (en) | 2007-11-22 |
ZA200810618B (en) | 2010-02-24 |
NZ572758A (en) | 2011-01-28 |
CN101472591A (zh) | 2009-07-01 |
AU2007250589A1 (en) | 2007-11-22 |
EP2023928A1 (en) | 2009-02-18 |
JP5254213B2 (ja) | 2013-08-07 |
CA2652500A1 (en) | 2007-11-22 |
EP2023928A4 (en) | 2012-08-29 |
JP2009537514A (ja) | 2009-10-29 |
WO2007133141A1 (en) | 2007-11-22 |
BRPI0712068A2 (pt) | 2012-01-17 |
KR101414063B1 (ko) | 2014-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20084987L (no) | Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel | |
MX2009012484A (es) | Formulacion de nicotina oral recubierta regulada con aminoacido. | |
NO20084992L (no) | Farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel | |
NO20084752L (no) | Konjugater av aziridinayl-epotilonanaloger og farmasoytiske sammensetninger som inneholder disse | |
NO20084541L (no) | Fuktig snussammensetning som ikke inneholder tobakk og fremgangsmate for fremstilling derav | |
PE20071250A1 (es) | Formulaciones farmaceuticas que comprenden pleconaril | |
RS54328B1 (en) | MULTIPLE TREATMENT OF LAKVINIMOD SCLEROSIS | |
AR078417A1 (es) | Composiciones de pelicula sublingual y bucal | |
WO2008069970A3 (en) | Nicotine formulations, kits and systems and methods for their use | |
RS51280B (sr) | Novi derivati hidantoina za tretman obstruktivnih bolesti dišnih puteva | |
AU2009215514A9 (en) | Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same | |
EA201071040A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1, cx3cr1 и p40 | |
MX2009011862A (es) | Composiciones farmaceuticas de administracion oronasofaringea de agonistas de la dopamina para la prevencion/alivio y/o tratamiento del desorden de miembros inquietos. | |
MY164646A (en) | Nicotine lozenge compositions | |
MX2008010172A (es) | Suministro pulmonar de inhibidor de proteinasa alafa-i. | |
EA201170520A1 (ru) | Ингибитор p38 mapk-киназы | |
MX2007004495A (es) | Composiciones y procedimientos para la administracion intranasal, bucal, sublingual y pulmonar de vareniclina. | |
MEP27308A (en) | Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual | |
RS54241B1 (en) | INHALATION COMPONENT CONTAINING ACLIDINIUM FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE | |
EA200970585A1 (ru) | Бензамидные производные как агонисты ер-рецепторов | |
MX2010003923A (es) | Formulacion farmaceutica de valsartan. | |
BRPI0922796A2 (pt) | Comprimido farmacêutico para administração por via oral e método de fabricação do mesmo | |
NO20075111L (no) | Farmasoytisk sammensetning | |
MX2010009625A (es) | Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40. | |
NO20090605L (no) | Metode for inhibering av respirasjonsdepresjon ved bruk av positive allosteriske AMPA reseptormodulatorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |